| Heading: |
Cancer: Genomics |
| Question ID: |
1787538 |
| UIN: |
40455 |
| House: |
Commons |
| Date tabled: |
2025-03-24 |
| Asking Member ID: |
4131 |
| Asking Member display name: |
Jim Shannon
|
| Asking Member handle: |
jimshannonmp
|
| Asking Member Twitter reference: |
@jimshannonmp
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the NHS's genomic testing capacity for patients diagnosed with cancer. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
Genomic testing in the National Health Service in England is provided through the NHS Genomic Medicine Service and delivered by a national genomic testing network of seven NHS Genomic Laboratory Hubs (GLHs). The NHS GLHs deliver testing as directed by the... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |